Simparica Trio 0.12 mg (Moxidectin TABLET (CHEWABLE)) 0.12 MG

Simparica Trio 0.12 mg chewable tablets provide broad-spectrum protection for dogs against fleas, ticks, heartworm, and intestinal parasites. This oral medication combines moxidectin for effective parasite control, ensuring your pet's health and comfort.

Strength

0.12 MG

Manufacturer / TM Owner

ZOETIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Simparica Trio 0.12 mg is primarily used for the prevention and treatment of flea and tick infestations in dogs. It also helps in controlling heartworm disease and treating intestinal parasites. This medication is suitable for dogs that require comprehensive parasite protection in a single, convenient chewable tablet.

Side Effects

Common effects of Simparica Trio 0.12 mg may include reduced flea and tick activity within 24 hours of administration. It works by targeting the nervous system of parasites, leading to their paralysis and death. Some dogs may experience mild gastrointestinal upset or lethargy after taking the medication.

Precautions & Warnings

Simparica Trio 0.12 mg should be used with caution in dogs with a history of seizures or neurological disorders. It is important to follow the dosage instructions provided by your veterinarian to ensure the safety and effectiveness of the medication. Always store the tablets in a cool, dry place away from children and pets.

Avoid Interactions

Simparica Trio 0.12 mg may interact with other medications, particularly those that affect the nervous system. It is important to inform your veterinarian about any other medications your dog is taking before starting this treatment. Avoid administering this medication with ivermectin or other macrocyclic lactones to prevent potential adverse reactions.

Frequently Asked Questions

Simparica Trio 0.12 mg is used to prevent and treat flea and tick infestations, control heartworm disease, and treat intestinal parasites in dogs.

Simparica Trio 0.12 mg works by targeting the nervous system of parasites, leading to their paralysis and death. It provides broad-spectrum protection against various parasites.

Simparica Trio 0.12 mg is typically recommended for dogs over a certain age and weight. Consult your veterinarian to determine if it is suitable for your puppy.

If your dog shows signs of an adverse reaction, such as vomiting, diarrhea, or lethargy, contact your veterinarian immediately for advice.

The frequency of administration depends on your dog's specific needs and the recommendations of your veterinarian. Typically, it is given monthly.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.